Liang, X., Li, H., Coussy, F., Callens, C., & Lerebours, F. (2019). An update on biomarkers of potential benefit with bevacizumab for breast cancer treatment: Do we make progress? Chin J Cancer Res.
Styl cytowania ChicagoLiang, Xu, Huiping Li, Florence Coussy, Celine Callens, i Florence Lerebours. "An Update On Biomarkers of Potential Benefit With Bevacizumab for Breast Cancer Treatment: Do We Make Progress?" Chin J Cancer Res 2019.
Styl cytowania MLALiang, Xu, et al. "An Update On Biomarkers of Potential Benefit With Bevacizumab for Breast Cancer Treatment: Do We Make Progress?" Chin J Cancer Res 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..